| (INR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 11.67B | — |
| Operating expense | — | — |
| Net income | 1.00B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AKUMS.NS returned +61.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +70.7% |
| 1 year | +61.8% |
| All-time high | ₹864.05 (Aug 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in AKUMS.NS would be worth today ›Yes. Akums Drugs and Pharmaceuticals Limited paid 1 dividend over the past 12 months. The most recent was ₹3.00 per share on Jul 3, 2026. The dividend yield is 0.13%.
Akums Drugs and Pharmaceuticals Limited is part of the Healthcare sector.
Akums Drugs and Pharmaceuticals Limited has a market cap of 114.07B INR, based on the latest quote.
